Kurdi Sawsan M, Alamer Ahmad, Alqarni Arjwan, AlQahtani Sara, AlKahlah Shahad, Alotaibi Fawaz M, Asiri Ibrahim M, Wali Haytham A
Department of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia.
Department of Clinical Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 16273, Saudi Arabia.
Healthcare (Basel). 2024 Jul 17;12(14):1425. doi: 10.3390/healthcare12141425.
Topical corticosteroids are commonly used to treat several skin conditions, most notably atopic dermatitis. Many studies have found that patients lack knowledge about the safety, potency, and appropriate use of topical corticosteroids. This can be due to ineffective education by pharmacists and other healthcare providers. This study aims to evaluate the appropriateness of dispensing and counseling practices of community pharmacists towards topical corticosteroids in Saudi Arabia.
A cross-sectional survey study was conducted in Saudi Arabia among 418 community pharmacists from different regions of Saudi Arabia. Data were collected using a validated questionnaire that covered community pharmacists' sociodemographic information, their perceptions of patient knowledge about topical corticosteroid use, and their dispensing and their counseling practices, in addition to their perceived barriers to counseling.
The majority of the participating community pharmacists were Saudi (57.4%), female (66.7%), holding a bachelor's degree (63.4%), and full-time workers (91.1%). Most of the time, community pharmacists counseled patients on the frequency of application per day and the duration of treatment (75.8% and 74.8%, respectively). The median counseling practice score was 17, with an IQR of 14-21. The main barrier to counseling was lack of time (33.7%). Only 15% of community pharmacists accurately identified all scenarios that necessitate medical referrals. Dry skin, itchiness, and irritation were the most common side effects reported by community pharmacists for patients to complain about (69.4%). Most pharmacists agreed that misuse is the most likely cause of topical corticosteroid adverse drug events (53.7%), followed by medication overuse, such as patient self-treatment (48%).
Community pharmacists counseling practices to their patients about the use of topical corticosteroids require improvement. Continuing education and hands-on training are needed for community pharmacists regarding counseling about topical corticosteroids use.
外用糖皮质激素常用于治疗多种皮肤疾病,最显著的是特应性皮炎。许多研究发现,患者缺乏关于外用糖皮质激素安全性、效力和正确使用方法的知识。这可能是由于药剂师和其他医疗服务提供者的教育效果不佳所致。本研究旨在评估沙特阿拉伯社区药剂师对外用糖皮质激素的配药和咨询实践的适宜性。
在沙特阿拉伯对来自沙特不同地区的418名社区药剂师进行了一项横断面调查研究。使用一份经过验证的问卷收集数据,该问卷涵盖社区药剂师的社会人口统计学信息、他们对患者外用糖皮质激素使用知识的看法、他们的配药和咨询实践,以及他们认为的咨询障碍。
大多数参与的社区药剂师是沙特人(57.4%),女性(66.7%),拥有学士学位(63.4%),并且是全职工作者(91.1%)。大多数时候,社区药剂师会就每日用药频率和治疗持续时间向患者提供咨询(分别为75.8%和74.8%)。咨询实践得分的中位数为17,四分位间距为14 - 21。咨询的主要障碍是时间不足(33.7%)。只有15%的社区药剂师能准确识别所有需要医疗转诊的情况。皮肤干燥、瘙痒和刺激是社区药剂师报告的患者最常抱怨的副作用(69.4%)。大多数药剂师认为滥用是外用糖皮质激素药物不良事件最可能的原因(53.7%),其次是用药过度,如患者自我治疗(48%)。
社区药剂师对患者外用糖皮质激素使用的咨询实践需要改进。需要为社区药剂师提供关于外用糖皮质激素使用咨询的继续教育和实践培训。